Elesta

Elesta's main product is EchoLaser. EchoLaser therapy can induce a process of cell reduction in benign lesions (such as BPH, thyroid nodules), or destroy cancerous tissue in malignant lesions (such as low-risk localized prostate cancer and kidney cancer, etc.). General anesthesia is usually not required. The procedure can be performed in an outpatient treatment plan, thus allowing for faster recovery after treatment.